PVLA — Palvella Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Palvella Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	70.4	118	59.2	26.4	83.6
Net Total Accounts Receivable
Net Total Receivables	1.71	3.31	5.81	6.04	2.34
Prepaid Expenses
Total Other Current Assets
Total Current Assets	75.7	128	73.4	38.7	88.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	26	23	20.7	0	—
Other Long Term Assets
Total Assets	105	154	95.5	38.7	88.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	22.1	50.6	36.6	11.9	12
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	74	103	67.6	11.9	25.6
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	31	50.8	27.9	26.8	62.6
Total Liabilities & Shareholders' Equity	105	154	95.5	38.7	88.2
Total Common Shares Outstanding
Total Preferred Shares Outstanding